TABLE 2.
Antigens used for developmenta
| Antigen | Pathogen | Optimum antigen concn (μg) | Purpose |
|---|---|---|---|
| p24-gp41 protein | HIV-1 | 1 | HIV-1 diagnosis |
| rIDR-M protein | HIV-2 | 0.04 | HIV-1/2 diagnosis |
| HIV-2 IDR peptide | HIV-2 | 10 | HIV-2 serotyping |
| p17-βgal | T. pallidum | 4.5 | Syphilis diagnosis |
| TmpA-βgal | T. pallidum | 1.5 | Syphilis diagnosis |
| HCV-239 | HCV | 1 | Hepatitis C diagnosis |
| HCV-11 | HCV | 0.5 | Hepatitis C diagnosis |
| HBV-270a | HBV | 10 | Hepatitis B diagnosis |
| HSV-1gG | HSV-1 | 1 | HSV-1 diagnosis |
| HSV-2gG | HSV-2 | 1 | HSV-2 diagnosis |
a
Critical assay parameters show the antigen used and the optimal antigen concentration for coupling, which was experimentally determined.